Evidence map›Paper›PMID 41672971›Full record

ArticleCell death & disease2026

CD36 enhances sensitivity of triple negative breast cancer cells to palmitate-induced ferroptosis.

Lara Closset, Jean-Philippe Foy, Lila Louadj, Elodie Pramil, Elisabetta Marangoni, Ivan Bieche, Michèle Sabbah

Abstract read
In one paragraph

Article in Cell death & disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lara ClossetCentre de Recherche Saint-Antoine, CRSA, Sorbonne Université, Inserm, Paris, France.
Jean-Philippe FoyCentre de Recherche Saint-Antoine, CRSA, Sorbonne Université, Inserm, Paris, France.
Lila LouadjCentre de Recherche Saint-Antoine, CRSA, Sorbonne Université, Inserm, Paris, France.
Elodie PramilCentre de Recherche Saint-Antoine, CRSA, Sorbonne Université, Inserm, Paris, France.
Elisabetta MarangoniLaboratory of Preclinical Investigation, Translational Research Department, Institut Curie, PSL University, Paris, France.
Ivan BiecheDepartment of Genetics, Institut Curie, Paris, France.
Michèle SabbahCentre de Recherche Saint-Antoine, CRSA, Sorbonne Université, Inserm, Paris, France. michele.sabbah@inserm.fr.ORCID http://orcid.org/0000-0001-5368-9022

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ferroptosis is a newly identified programmed cell death induced by iron-driven lipid peroxidation and implicated as a potential approach for tumor treatment. Breast tumors develop in a complex microenvironment whose main component is adipose tissue and gain aggressiveness through increased fatty acid uptake. Here, we demonstrated that palmitic acid (PA) induced ferroptosis in triple negative breast cancers (TNBC). We found that PA increases the protein expression levels of the long-chain fatty acid transporter CD36, leading to increased lipid uptake. Mechanistically, overexpression of CD36 increases lipid peroxidation, mitochondrial ROS production, the labile iron pool, and especially Fe

Indexed as

CD36 AntigensFerroptosisPalmitatesPalmitic AcidTriple Negative Breast NeoplasmsAnimalsCell Line, TumorFemaleGene Expression Regulation, NeoplasticHumansIronLipid PeroxidationMitochondriaReactive Oxygen SpeciesCD36 AntigensCD36 protein, humanIronPalmitatesPalmitic AcidReactive Oxygen Species

Identifiers

PMID41672971
PMCPMC12920903

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.